{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:42:15Z","timestamp":1790030535913,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.jaut.2016.11.004","type":"journal-article","created":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T02:09:38Z","timestamp":1480471778000},"page":"38-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["Outcome of pregnancy and neonatal complications with anti-tumor necrosis factor-\u03b1 use in females with immune mediated diseases; a systematic review and meta-analysis"],"prefix":"10.1016","volume":"76","author":[{"given":"Fukiko","family":"Komaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuga","family":"Komaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejan","family":"Micic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Ido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2519-6129","authenticated-orcid":false,"given":"Atsushi","family":"Sakuraba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2016.11.004_bib1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.reprotox.2013.11.004","article-title":"Pregnancy outcome following gestational exposure to TNF-alpha-inhibitors: a prospective, comparative, observational study","volume":"43","author":"Diav-Citrin","year":"2014","journal-title":"Reprod. Toxicol."},{"issue":"2","key":"10.1016\/j.jaut.2016.11.004_bib2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cgh.2015.08.039","article-title":"Low risk of birth defects for infants whose mothers are treated with anti-tumor necrosis factor agents during pregnancy","volume":"14","author":"Broms","year":"2016","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jaut.2016.11.004_bib3","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.cgh.2006.03.002","article-title":"Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry","volume":"4","author":"Lichtenstein","year":"2006","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jaut.2016.11.004_bib4","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1111\/j.1572-0241.2004.30186.x","article-title":"Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis","volume":"99","author":"Katz","year":"2004","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2016.11.004_bib5","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1002\/ibd.21583","article-title":"Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy","volume":"17","author":"Schnitzler","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.jaut.2016.11.004_bib6","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2174\/138161212799504759","article-title":"Adverse cardiovascular effects of antirheumatic drugs: implications for clinical practice and research","volume":"18","author":"Gasparyan","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jaut.2016.11.004_bib7","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.mayocp.2012.04.011","article-title":"Vasculitis associated with tumor necrosis factor-alpha inhibitors","volume":"87","author":"Sokumbi","year":"2012","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jaut.2016.11.004_bib8","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1007\/s10620-006-9452-2","article-title":"The successful use of adalimumab to treat active Crohn's disease of an ileoanal pouch during pregnancy","volume":"51","author":"Coburn","year":"2006","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jaut.2016.11.004_bib9","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/00054725-200608000-00020","article-title":"Successful use of adalimumab (Humira) for Crohn's disease in pregnancy","volume":"12","author":"Mishkin","year":"2006","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.jaut.2016.11.004_bib10","first-page":"196","article-title":"Adalimumab: human recombinant immunoglobulin g1 anti-tumor necrosis factor monoclonal antibody","volume":"4","author":"Baker","year":"2004","journal-title":"Rev. Gastroenterol. Disord."},{"key":"10.1016\/j.jaut.2016.11.004_bib11","doi-asserted-by":"crossref","first-page":"A-146","DOI":"10.1016\/S0016-5085(09)60658-2","article-title":"960 certolizumab use in pregnancy: low levels detected in cord blood","volume":"136","author":"Mahadevan","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2016.11.004_bib12","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1097\/MIB.0000000000000092","article-title":"Anti-TNF\u03b1 therapies are safe during pregnancy in women with inflammatory bowel disease: a systematic review and meta-analysis","volume":"20","author":"Narula","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.jaut.2016.11.004_bib13","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J.\u00a0Clin. Epidemiol."},{"key":"10.1016\/j.jaut.2016.11.004_bib14","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"10.1016\/j.jaut.2016.11.004_bib15","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann. Intern Med."},{"key":"10.1016\/j.jaut.2016.11.004_bib16","series-title":"The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-analyses [Internet]","first-page":"2015","author":"Wells","year":"2014"},{"key":"10.1016\/j.jaut.2016.11.004_bib17","first-page":"1","article-title":"Alcohol and mortality after moderate to severe traumatic brain injury: a meta-analysis of observational studies","author":"Raj","year":"2015","journal-title":"J.\u00a0Neurosurg."},{"key":"10.1016\/j.jaut.2016.11.004_bib18","first-page":"2731","article-title":"Prognostic role of neutrophil to lymphocyte ratio in lung cancers: a meta-analysis including 7,054 patients","volume":"8","author":"Zhao","year":"2015","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.jaut.2016.11.004_bib19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jaut.2016.11.004_bib20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jrsm.13","article-title":"Critical interpretation of Cochran's Q test depends on power and prior assumptions about heterogeneity","volume":"1","author":"Pereira","year":"2010","journal-title":"Res. Synth. Methods"},{"key":"10.1016\/j.jaut.2016.11.004_bib21","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/j.jaut.2016.11.004_bib22","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.jaut.2016.11.004_bib23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J.\u00a0Clin. Epidemiol."},{"key":"10.1016\/j.jaut.2016.11.004_bib24","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.dss.2012.10.005","article-title":"ADDIS: a decision support system for evidence-based medicine","volume":"55","author":"Van Valkenhoef","year":"2013","journal-title":"Decis. Support Syst."},{"key":"10.1016\/j.jaut.2016.11.004_bib25","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cgh.2012.10.024","article-title":"Effects of discontinuing anti-tumor necrosis factor therapy during pregnancy on the course of inflammatory bowel disease and neonatal exposure","volume":"11","author":"Zelinkova","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jaut.2016.11.004_bib26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/pds.2046","article-title":"Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data","volume":"20","author":"Askling","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"10.1016\/j.jaut.2016.11.004_bib27","doi-asserted-by":"crossref","first-page":"f1342","DOI":"10.1136\/bmj.f1342","article-title":"Meta-analyses: how to read a funnel plot","volume":"346","author":"Sedgwick","year":"2013","journal-title":"Br. Med. J."},{"issue":"8","key":"10.1016\/j.jaut.2016.11.004_bib28","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1136\/gutjnl-2015-309321","article-title":"Tailored anti-TNF therapy during pregnancy in patients with IBD: maternal and fetal safety","volume":"65","author":"de Lima","year":"2016","journal-title":"Gut."},{"key":"10.1016\/j.jaut.2016.11.004_bib29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ibd.22948","article-title":"Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease","volume":"19","author":"Akbari","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.jaut.2016.11.004_bib30","doi-asserted-by":"crossref","first-page":"A-27","DOI":"10.1016\/S0016-5085(09)60125-6","article-title":"142 pregnancy outcomes in women exposed to adalimumab: the OTIS autoimmune diseases in pregnancy project","volume":"136","author":"Johnson","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2016.11.004_bib31","doi-asserted-by":"crossref","first-page":"S-149","DOI":"10.1016\/S0016-5085(12)60561-7","article-title":"865 PIANO: a 1000 patient prospective registry of pregnancy outcomes in women with IBD exposed to immunomodulators and biologic therapy","volume":"142","author":"Mahadevan","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2016.11.004_bib32","first-page":"A65","article-title":"Pregnancy outcomes in patients with Crohn's disease treated with infliximab: results from the treat (TM) registry","volume":"1","author":"Lichtenstein","year":"2013","journal-title":"United Eur. Gastroenterol. J."},{"key":"10.1016\/j.jaut.2016.11.004_bib33","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/ajg.2012.430","article-title":"Safety of thiopurines and anti-TNF-alpha drugs during pregnancy in patients with inflammatory bowel disease","volume":"108","author":"Casanova","year":"2013","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2016.11.004_bib34","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/apt.12833","article-title":"Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease","volume":"40","author":"Seirafi","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jaut.2016.11.004_bib35","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/ard.2010.140822","article-title":"Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology biologics register","volume":"70","author":"Verstappen","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.11.004_bib36","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/bcp.12642","article-title":"Pregnancy outcome after TNF-alpha inhibitor therapy during the first trimester: a prospective multicentre cohort study","volume":"80","author":"Weber-Schoendorfer","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jaut.2016.11.004_bib37","unstructured":"C. Chambers, D. Johnson, K. Jones. Safety of anti-TNF-alpha medications in pregnancy. Journal of the American Academy of Dermatology: Mosby, Inc 11830 Westline Industrial DR, St Louis, MO 63146\u20133318 USA; 2005, p. AB8-AB."},{"key":"10.1016\/j.jaut.2016.11.004_bib38","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/annrheumdis-2015-eular.1971","article-title":"SAT0159 long-term follow-up of children born to mothers with chronic arthritides and exposed in utero to anti-TNF-alpha agents: a case-control study","volume":"74","author":"Agosti","year":"2015","journal-title":"Ann. Rheumatic Dis."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841116302591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841116302591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:15:02Z","timestamp":1760256902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841116302591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":38,"alternative-id":["S0896841116302591"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2016.11.004","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcome of pregnancy and neonatal complications with anti-tumor necrosis factor-\u03b1 use in females with immune mediated diseases; a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2016.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}